Journey Medical: A Small Pharma With A Large Growth Opportunity (NASDAQ:DERM)
· seekingalpha.com
Journey Medical (DERM) is rated Buy, driven by Emrosi’s rapid prescription growth and expanding payer coverage.
Journey Medical ( DERM ) has a new winning product in Emrosi, and it's gaining traction with dermatologists and patients as more people get experience with the ...